You are here: Industry Insights > COVID-19

News List

Pharma units in Sikkim affected by COVID-19, production slashed by 25-30 per cent expresspharma
August 13, 2020
Presently, the State has approximately 48 pharma units and around 10 pharma units have been declared as active containment zones by the local authorities.
What the rest of the world can learn from South Korea's COVID-19 response worldpharmanews
August 12, 2020
As the world continues to closely monitor the newest coronavirus outbreak, the government of South Korea has been able to keep the disease under control without paralyzing the national health and economic systems.
FDA Grants Inhaled Use IND for RLF-100 for COVID-19 to Prevent Respiratory Failure americanpharmaceuticalreview
August 12, 2020
NeuroRx and Relief Therapeutics announced NeuroRx has been granted Investigational New Drug (IND) permission to test RLF-100 (aviptadil) for inhaled use in patients with moderate and severe COVID-19 in order to prevent progression to respiratory failure.
PTx Announces Contract with DOD for Leukine for COVID-19 Associated Acute Hypoxemia americanpharmaceuticalreview
August 12, 2020
Partner Therapeutics (PTx) anounced a $35 million milestone-based Other Transaction Agreement (OTA) with the U.S. Department of Defense (DOD).
FDA issues Emergency Use Authorization to Vela Diagnostics' Coronavirus PCR Test americanpharmaceuticalreview
August 12, 2020
Vela Diagnostics announced the manual version of its coronavirus PCR test has obtained Emergency Use Authorization from the U.S. Food and Drug Administration (FDA).
Gilead seeks full approval for remdesivir from US FDA for COVID-19 treatment expresspharma
August 12, 2020
To boost the drug’s availability globally, Gilead has signed multiple manufacturing and supply deals, including with Pfizer and Britain’s Hikma Pharmaceuticals.
Daewoong Pharma gets CDSCO nod to test anti-parasite drug for COVID-19 expresspharma
August 12, 2020
The South Korean drugmaker is testing the drug in partnership with Mankind Pharma which will continue the second and third phases of trials in India on mild and severe coronavirus patients.
Researchers say hydroxychloroquine could still prevent COVID-19 pharmatimes
August 11, 2020
Leading scientific researchers from the University of Oxford have said that the antiviral medication hydroxychloroquine is being ‘discarded prematurely’ and could still have benefit against COVID-19.
Bio-Techne, Kantaro Biosciences to Launch Quantitative Research Use Only COVID-19 Serology Test americanpharmaceuticalreview
August 11, 2020
Bio-Techne and the Mount Sinai Health System in New York, through its commercial affiliate Kantaro Biosciences, announced the anticipated launch of the COVID-SeroIndex, a Kantaro Quantitative SARS-CoV-2 IgG Antibody RUO kit.
COVID R&D Alliance, Quantum Leap Healthcare Collaborative Enroll First Patients in COVID Trial americanpharmaceuticalreview
August 11, 2020
Members of the COVID R&D Alliance AbbVie, Amgen, and Takeda Pharmaceutical announced the first patients enrolled in the I-SPY COVID Trial (Investigation of Serial Studies to Predict Your COVID Therapeutic Response with Biomarker Integration and ...